LTR Pharma (ASX:LTP) said its increased its stake in its co-founded firm LevOmega to 43% from 33%, following a AU$1 million investment by the company's unit LTR Spectrum, according to a Monday filing with the Australian bourse.
LTR Pharma (ASX:LTP) said its increased its stake in its co-founded firm LevOmega to 43% from 33%, following a AU$1 million investment by the company's unit LTR Spectrum, according to a Monday filing with the Australian bourse.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.